Standout Papers
Citation Impact
Citing Papers
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
2009 Standout
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
2012 Standout
A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor–Positive Breast Cancer
2010
A 50-Gene Intrinsic Subtype Classifier for Prognosis and Prediction of Benefit from Adjuvant Tamoxifen
2012
Genetic Reclassification of Histologic Grade Delineates New Clinical Subtypes of Breast Cancer
2006
The Humoral Immune System Has a Key Prognostic Impact in Node-Negative Breast Cancer
2008
Lung metastasis genes couple breast tumor size and metastatic spread
2007
PD-L1 Expression Correlates with Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy in Breast Cancer
2014
Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009
2009
Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis
2014 StandoutNobel
Mechanisms of Endocrine Resistance in Breast Cancer
2010
Concordance among Gene-Expression–Based Predictors for Breast Cancer
2006
Breast Cancer Subtype Approximated by Estrogen Receptor, Progesterone Receptor, and HER-2 Is Associated With Local and Distant Recurrence After Breast-Conserving Therapy
2008
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
2009 Standout
Comprehensive molecular portraits of human breast tumours
2012 StandoutNature
Biologic markers determine both the risk and the timing of recurrence in breast cancer
2011
Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
2011 Standout
Mutational landscape and significance across 12 major cancer types
2013 StandoutNature
Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancer
2010
Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes
2008
Is gene array testing to be considered routine now?
2011
The functional loss of the retinoblastoma tumour suppressor is a common event in basal-like and luminal B breast carcinomas
2008
Inclusion of KI67 significantly improves performance of the PREDICT prognostication and prediction model for early breast cancer
2014
Hallmarks of Cancer: The Next Generation
2011 Standout
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients
2007
The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes
2007 Standout
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Predictors of Resistance to Preoperative Trastuzumab and Vinorelbine for HER2-Positive Early Breast Cancer
2007
Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy
2005
Endogenous human microRNAs that suppress breast cancer metastasis
2008 StandoutNature
A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF- B and enhanced IRF-3/STAT1 activation)
2005
A gene-expression signature to predict survival in breast cancer across independent data sets
2006
Gene Pathways Associated With Prognosis and Chemotherapy Sensitivity in Molecular Subtypes of Breast Cancer
2010
Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: Long-term follow up on IBCSG Trial IX
2011
A view on drug resistance in cancer
2019 StandoutNature
Genes that mediate breast cancer metastasis to the brain
2009 StandoutNature
Personalized treatment of early-stage breast cancer: Present concepts and future directions
2010
Breast cancer
2016 Standout
Role of tumor-associated macrophages in tumor progression and invasion
2006
Association of a Leukemic Stem Cell Gene Expression Signature With Clinical Outcomes in Acute Myeloid Leukemia
2010
Origins of breast cancer subtypes and therapeutic implications
2007
Mediators of vascular remodelling co-opted for sequential steps in lung metastasis
2007 Nature
Comparison of the prognostic and predictive utilities of the 21-gene Recurrence Score assay and Adjuvant! for women with node-negative, ER-positive breast cancer: results from NSABP B-14 and NSABP B-20
2011
Chronic myeloid leukaemia as a model of disease evolution in human cancer
2007
Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex
2014 StandoutNature
Imaging in the era of molecular oncology
2008 StandoutNature
Profiling the Breast Cancer Proteome — The New Tool of the Future?
2006
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Implication of tumor microenvironment in the resistance to chemotherapy in breast cancer patients
2010
Mining gene expression profiles: expression signatures as cancer phenotypes
2007
Ki-67 as a prognostic marker according to breast cancer subtype and a predictor of recurrence time in primary breast cancer
2010
Differential oestrogen receptor binding is associated with clinical outcome in breast cancer
2012 StandoutNature
Preoperative Magnetic Resonance Imaging in Breast Cancer
2012
Surgical Margins in Lumpectomy for Breast Cancer — Bigger Is Not Better
2012
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
2010 Standout
Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures
2008
Analyzing real-time PCR data by the comparative CT method
2008 Standout
Genetic determinants of cancer metastasis
2007
Histological and molecular types of breast cancer: is there a unifying taxonomy?
2009
Estrogen-Receptor Status and Outcomes of Modern Chemotherapy for Patients With Node-Positive Breast Cancer
2006
Breast Cancer Metastasis
2013
Population-based screening for cancer: hope and hype
2016
Insight into the heterogeneity of breast cancer through next-generation sequencing
2011
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
2012 Standout
Integrated genomic characterization of endometrial carcinoma
2013 StandoutNature
Prognostic Value of Ki67 Expression After Short-Term Presurgical Endocrine Therapy for Primary Breast Cancer
2007
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene‐expression subtypes of breast cancer
2006
Surgical Management of the Breast
2013
Gene expression predictors in breast cancer: Current status, limitations and perspectives
2008
Immunity, Inflammation, and Cancer
2010 Standout
Identifying Site-specific Metastasis Genes and Functions
2005
Hazard of recurrence and adjuvant treatment effects over time in lymph node-negative breast cancer
2008
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
The predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer
2010
The causes and consequences of genetic heterogeneity in cancer evolution
2013 StandoutNature
A single-sample microarray normalization method to facilitate personalized-medicine workflows
2012
multifunctional enzymes in cancer
2006
Gene-Expression Signatures in Breast Cancer
2009
Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis
2011 Standout
GOBO: Gene Expression-Based Outcome for Breast Cancer Online
2011
SWELL1, a Plasma Membrane Protein, Is an Essential Component of Volume-Regulated Anion Channel
2014 StandoutNobel
Gene expression profiling in single cells within tissue
2005
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
2015 StandoutNature
Heterogeneity of breast cancer and implications of adjuvant chemotherapy
2007
Molecular mechanisms of metastasis in breast cancer—clinical applications
2010
Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patients
2013
Adjuvant therapies for special types of breast cancer
2011
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Genes that mediate breast cancer metastasis to lung
2005 StandoutNature
Cancer-related inflammation
2008 StandoutNature
Biological determinants of endocrine resistance in breast cancer
2009
Chemotherapy in Early Breast Cancer: When, How and Which One?
2014
Surgical issues in patients with breast cancer receiving neoadjuvant chemotherapy
2015
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
2009 Standout
The prognostic landscape of genes and infiltrating immune cells across human cancers
2015 Standout
First international consensus guidelines for breast cancer in young women (BCY1)
2014
Preservation of Fertility in Patients with Cancer
2009 Standout
Tumor Markers in Breast Cancer – European Group on Tumor Markers Recommendations
2005
Cancer related inflammation: The macrophage connection
2008
Breast cancer metastasis: markers and models
2005 Standout
Deconstructing the molecular portraits of breast cancer
2010
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
2018 Standout
The Prognostic Role of a Gene Signature from Tumorigenic Breast-Cancer Cells
2007
Comparison of PAM50 Risk of Recurrence Score With Oncotype DX and IHC4 for Predicting Risk of Distant Recurrence After Endocrine Therapy
2013
CXCL4 mediates tumor regrowth after chemotherapy by suppression of antitumor immunity
2015
β-Arrestin2 mediates the initiation and progression of myeloid leukemia
2012 StandoutNobel
Estrogen- and Progesterone-Receptor Status in ECOG 2197: Comparison of Immunohistochemistry by Local and Central Laboratories and Quantitative Reverse Transcription Polymerase Chain Reaction by Central Laboratory
2008
Gene Expression Profiling of Breast Cancer: A New Tumor Marker
2005
Breast Cancer Prognosis Determined by Gene Expression Profiling: A Quantitative Reverse Transcriptase Polymerase Chain Reaction Study
2005
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
2001 Standout
Use of gene expression profiling to direct in vivo molecular imaging of lung cancer
2005
Long-Term Follow-Up of the E1199 Phase III Trial Evaluating the Role of Taxane and Schedule in Operable Breast Cancer
2015
Ferroportin and Iron Regulation in Breast Cancer Progression and Prognosis
2010
A Perspective on Cancer Cell Metastasis
2011 StandoutScience
Micrometastatic Disease and Metastatic Outgrowth: Clinical Issues and Experimental Approaches
2009
Economic analysis of targeting chemotherapy (CT) using a 21 gene RT-PCR assay in lymph node negative (LN-), estrogen receptor positive (ER+) early-stage breast cancer (ESBC)
2004
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
Estrogen-Regulated Genes Predict Survival in Hormone Receptor–Positive Breast Cancers
2006
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
Agreement in Breast Cancer Classification between Microarray and Quantitative Reverse Transcription PCR from Fresh-Frozen and Formalin-Fixed, Paraffin-Embedded Tissues
2007
Breast Cancer Subtypes and Response to Docetaxel in Node-Positive Breast Cancer: Use of an Immunohistochemical Definition in the BCIRG 001 Trial
2009
Prognostic Significance of Progesterone Receptor–Positive Tumor Cells Within Immunohistochemically Defined Luminal A Breast Cancer
2012
A Two-Gene Expression Ratio of Homeobox 13 and Interleukin-17B Receptor for Prediction of Recurrence and Survival in Women Receiving Adjuvant Tamoxifen
2006
Metabolic reprogramming and cancer progression
2020 StandoutScience
Cancer Genome Landscapes
2013 StandoutScience
Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer
2009
Pharmacogenomic Predictor of Sensitivity to Preoperative Chemotherapy With Paclitaxel and Fluorouracil, Doxorubicin, and Cyclophosphamide in Breast Cancer
2006
NCCN Task Force Report: Adjuvant Therapy for Breast Cancer
2006
Multidisciplinary Meeting on Male Breast Cancer: Summary and Research Recommendations
2010 Standout
Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis
2006 Standout
GATA-3 Expression in Breast Cancer Has a Strong Association with Estrogen Receptor but Lacks Independent Prognostic Value
2008
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27
2008
Multicenter Validation of a Gene Expression–Based Prognostic Signature in Lymph Node–Negative Primary Breast Cancer
2006
Ferroportin and Iron Regulation in Breast Cancer Progression and Prognosis
2010
Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
2015 StandoutNobel
Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment
2014 StandoutNobel
Gene Expression Profiling of Breast Cancer
2008
Definition of Clinically Distinct Molecular Subtypes in Estrogen Receptor–Positive Breast Carcinomas Through Genomic Grade
2007
The HOXB13:IL17BR Expression Index Is a Prognostic Factor in Early-Stage Breast Cancer
2006
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials
2012
Integrated microfluidic bioprocessor for single-cell gene expression analysis
2008 StandoutNobel
Works of Drew Watson being referenced
Relationship Between Tumor Gene Expression and Recurrence in Four Independent Studies of Patients With Stage II/III Colon Cancer Treated With Surgery Alone or Surgery Plus Adjuvant Fluorouracil Plus Leucovorin
2010
A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients
2006
Prognostic Role of a Multigene Reverse Transcriptase-PCR Assay in Patients with Node-Negative Breast Cancer Not Receiving Adjuvant Systemic Therapy
2005
Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer
2006 Standout
Predicting response to primary chemotherapy: gene expression profiling of paraffin-embedded core biopsy tissue
2006
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
2004 Standout
Analytical Validation of the Oncotype DX Genomic Diagnostic Test for Recurrence Prognosis and Therapeutic Response Prediction in Node-Negative, Estrogen Receptor–Positive Breast Cancer
2007
Expression of the 21 genes in the Recurrence Score assay and tamoxifen clinical benefit in the NSABP study B-14 of node negative, estrogen receptor positive breast cancer
2005
Association Between the 21-Gene Recurrence Score Assay and Risk of Locoregional Recurrence in Node-Negative, Estrogen Receptor–Positive Breast Cancer: Results From NSABP B-14 and NSABP B-20
2010
Gene expression and breast cancer mortality in Northern California Kaiser Permanente Patients: A large population-based case control study
2005
Gene Expression Profiles in Paraffin-Embedded Core Biopsy Tissue Predict Response to Chemotherapy in Women With Locally Advanced Breast Cancer
2005
Molecular characterization of male breast cancer by standardized quantitative RT-PCR analysis: First large genomic study of 347 male breast cancers compared to 82,434 female breast cancers
2009